FindTrial
Sign In

Dose self-management of oral anticoagulation therapy improve anxiety and depression? A randomized controlled trial

Dose self-management of oral anticoagulation therapy improve anxiety and depression? A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020775
Enrollment
Unknown
Registered
2019-01-19
Start date
2019-01-21
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

valvular heart disease

Interventions

Group 1:Self-management of oral anticoagulation
Group 2:Traditional management

Sponsors

The Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: underwent valvular repair or replace surgery, require oral anticoagulation postoperatively, aged at least 18 years.

Exclusion criteria

Exclusion criteria: previous cardiac surgery, already on anticoagulation preoperatively, history of mental illness, do not have the intelligence and language ability to complete the questionnaire, not capable of self-management

Design outcomes

Primary

MeasureTime frame
The State–Trait Anxiety Inventory (STAI) ;The Beck Depression Inventory(BDI);Duke Anticoagulation Satisfaction Scale(DASS) ;—

Countries

China

Contacts

Public ContactMu Mingchao

The Second Affiliated Hospital of Xi'an Jiaotong University

380388269@qq.com+86 17792519318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026